Marker Therapeutics, Inc. — Director's Dealing 2015

Nov 16, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2015-11-12

Reporting Person: Grisewood Sherry (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-12	Employee Stock Option (Right to Buy)	$0.605	A	150000	Acquired	2025-11-12	Common Stock (150000)	Direct

Footnotes

F1: Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan in connection with service as a director of the Company. These shares vest immediately. The option exercise price is the closing price on the date of the grant, November 12, 2015.